Third degree atrioventricular block associated with treatment with rivastigmine transdermal patch

Rivastigmine transdermal patch is indicated for patients with Alzheimer's disease and dementia with Parkinson's disease. Rivastigmine, an acetylcholinesterase inhibitor, has several common adverse effects, mainly involving the gastrointestinal tract, but few cardiovascular adverse effects...

Descripción completa

Detalles Bibliográficos
Autores principales: Knudtzen, Fredrikke C., Christophersen, Thomas B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Science Press 2013
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3627713/
https://www.ncbi.nlm.nih.gov/pubmed/23610582
http://dx.doi.org/10.3969/j.issn.1671-5411.2013.01.017

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3627713/
https://www.ncbi.nlm.nih.gov/pubmed/23610582
http://dx.doi.org/10.3969/j.issn.1671-5411.2013.01.017

Ejemplares similares